<bill session="117" type="s" number="4152" updated="2022-12-29T16:33:52Z">
  <state datetime="2022-05-05">REFERRED</state>
  <status>
    <introduced datetime="2022-05-05"/>
  </status>
  <introduced datetime="2022-05-05"/>
  <titles>
    <title type="display">A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.</title>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.</title>
  </titles>
  <sponsor bioguide_id="K000377"/>
  <cosponsors>
    <cosponsor bioguide_id="C001035" joined="2022-05-05"/>
    <cosponsor bioguide_id="S001191" joined="2022-05-05"/>
  </cosponsors>
  <actions>
    <action datetime="2022-05-05">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2022-05-05" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="7667" relation="unknown"/>
    <bill session="117" type="h" number="7658" relation="identical"/>
    <bill session="117" type="s" number="4348" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-10-18T14:51:18Z" status="Introduced in Senate">This bill reauthorizes through FY2027 the Food and Drug Administration's Critical Path Public-Private Partnerships, which support medical product innovation, development, and safety.</summary>
</bill>
